ArticleRSC advances2020
Promising performance of chemically exfoliated Zr-doped MoS
Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- First-Principles Design Rules for Selective Room-Temperature Gas Sensing in Transition-Metal-Doped MoSACS applied materials & interfaces · 2026Article
- MoSRSC advances · 2026Article
- Enhancement of commercial dye photocatalytic degradation through the use of silver-doped kaolinite-zinc oxide quantum dots.BMC chemistry · 2025Article
- Hydrothermally synthesized VSScientific reports · 2025Article
- Emerging trends and future challenges of advanced 2D nanomaterials for combating bacterial resistance.Bioactive materials · 2024Review
- Role of transition metals in coinage metal nanoclusters for the remediation of toxic dyes in aqueous systems.RSC advances · 2024Review
- Using biologically synthesized TiOScientific reports · 2023Article
- Antimicrobial and anti-viral effects of selenium nanoparticles and selenoprotein based strategies: COVID-19 and beyond.Journal of drug delivery science and technology · 2023Review
- Experimental and theoretical study of catalytic dye degradation and bactericidal potential of multiple phase Bi and MoSRSC advances · 2023Article
- Article
- Photocatalytic and antibacterial activity of graphene oxide/cellulose-doped TiONanoscale advances · 2022Article
- Enhanced Photocatalytic Degradation with Sustainable CaO Nanorods Doped with Ce and Cellulose Nanocrystals: In Silico Molecular Docking Studies.ACS omega · 2022Article
- Enhanced Bactericidal Action of rGO-ZnO Hybrids Prepared by the One-Pot Co-precipitation Approach.ACS omega · 2022Article
- One-step high-yield preparation of nitrogen- and sulfur-codoped carbon dots with applications in chromium(vi) and ascorbic acid detection.RSC advances · 2022Article
- Article
- Cytotoxic and photocatalytic studies of hexagonal boron nitride nanotubes: a potential candidate for wastewater and air treatment.RSC advances · 2022Article
- Nitrogen and Carbon Nitride-Doped TiONanoscale research letters · 2021Article
- A review on bismuth oxyhalide based materials for photocatalysis.Nanoscale advances · 2021Review
- Impact of Bi Doping into Boron Nitride Nanosheets on Electronic and Optical Properties Using Theoretical Calculations and Experiments.Nanoscale research letters · 2021Article
- Algae-mediated route to biogenic cuprous oxide nanoparticles and spindle-like CaCORSC advances · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanostructured materials incorporated with biological reducing agents have shown significant potential for use in bactericidal applications. Such materials have also demonstrated considerable efficacy to counter effects of chemical toxicity. In this study, nanostructured molybdenum disulfide (MoS
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.